Trial Details
UNKNOWNBasic Information
| Clinical ID | c1019 |
|---|---|
| Identifier | NCT05687435 |
| Trial Title | Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Diarrhea-Predominant Irritable Bowel Syndrome |
| Interventions | DRUG: Changyanning tablet|OTHER: Changyanning tablet placebo |
Participant Information
| Sponsor | Mei Han |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2023-01-30 |
|---|---|
| Primary Completion Date | 2023-01-31 |
| Completion Date | 2024-04-30 |